Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
AIkido Pharma
SPEX
Healthcare
Biotechnology
AIkido Pharma Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SPEX)
New Post
View:
Posts & Comments
Threaded Posts
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Sep 28, 2021 11:28pm
AIKI - Tuesday Rundown, Wednesday Expectations
(2)
•••
HampsStockstar
X
View Profile
View Bullboard History
Post by
HampsStockstar
on Aug 01, 2021 9:20pm
Mark G. Gomez Co-Founder of Canna Ventures, LLC likes $AIKI
On a recent appearance of Investing Today podcast he mentioned a few #Shrooms #Psilocybin plays such as $MNMD $MYCOF $ATAI $LRSV $AIKI $SILO and said the over all sector is where cannabis was 5 yrs
...more
(7)
•••
fnapts
X
View Profile
View Bullboard History
Comment by
fnapts
on Feb 25, 2021 12:27pm
RE:RE:RE:Terrible game played by this company
This is silly. $86.2 million invested at $1.60, now trading at a 20% discount.
(7)
•••
fnapts
X
View Profile
View Bullboard History
Comment by
fnapts
on Feb 24, 2021 2:31pm
RE:RE:Terrible game played by this company
Bought in PM. Wish I saw this a couple days ago, I would have loaded up on those shares that sold near $1.
(7)
•••
fnapts
X
View Profile
View Bullboard History
Comment by
fnapts
on Feb 23, 2021 11:13pm
RE:Terrible game played by this company
They closed a $86.2 million bought deal at $1.60 (upsized from $10 million) without warrants. Seriously?
(2)
•••
taff3
X
View Profile
View Bullboard History
Post by
taff3
on Apr 14, 2020 3:50pm
Terrible game played by this company
Especially for the longs who held through the name change but they were rewarded today with great news AIkido Pharma Executes Exclusive World-Wide License to Broad Spectrum Antiviral Drug Platform
...more
(42)
•••
thedave2006
X
View Profile
View Bullboard History
Comment by
thedave2006
on Mar 11, 2020 11:34am
RE:Definitive agreement announced yesterday, @ $2.75,
pump a doodle do on twitter feeds?
(0)
•••
Subchimes1
X
View Profile
View Bullboard History
Post by
Subchimes1
on Mar 10, 2020 1:55pm
Definitive agreement announced yesterday, @ $2.75,
Definitive agreement announced On March 9th, for 5.75 million, @$2.75, why are we trading below that today? Press release, should close at or around March 11th, looks like its trading very cheap
...more
(2)
•••
taff3
X
View Profile
View Bullboard History
Comment by
taff3
on Mar 06, 2020 10:22am
RE:it's a buy today for me
Spherix Executes Option to License Patented Treatment for Coronavirus NEW YORK, March 6, 2020 /PRNewswire/ -- Spherix Incorporated (Nasdaq: SPEX) today announced it has executed an
...more
(668)
•••
coolfooldumbguy
X
View Profile
View Bullboard History
Post by
coolfooldumbguy
on Nov 26, 2018 10:21am
it's a buy today for me
this is an up and coming area with big potential,so glta.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project